Medical Marijuana, Inc. (MJNA) Announces Exclusive Seven Day Cruise from San Diego, California, to Cabo San Lucas, Mexico

The incentive event will celebrate the top leaders in the Kannaway® family. “We look forward to engaging our Kannaway® leaders on our inaugural Incentive Trip,” said Kannaway® CEO Blake Schroeder. “Over 70 Kannaway distributorships qualified for the cruise, well beyond our expectations, and we are looking forward to celebrating our successes together.”

Participants will hear from executive team members including Kannaway® CEO Blake Schroeder, Kannaway® President Brad Tayles, CEO of Kannaway® parent company Medical Marijuana, Inc. Dr. Stuart Titus, and President and CEO of ECHO Connection Andrea Barnes.

The seven-day cruise returns to the San Diego harbor on Oct. 14, 2017.

About Kannaway, LLC 
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who wish to become successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
andrew.hard@cmwmedia.com
www.cmwmedia.com